Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 3/20 | 0.37 |
| ▸ | BTK | Q06187 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LPL | P06858 | 3/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.34 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18563346 | 0.79 | AHR (0.43) | JAK2BTKLPLLIPG | |
| SCHEMBL21392426 | 0.77 | JAK2 (0.30) | JAK2BTK | |
| SCHEMBL31676557 | 0.77 | P2RX4 (0.35) | JAK2BTKLPLLIPGP2RX4 | |
| SCHEMBL20565735 | 0.76 | LPL (0.43) | LPLLIPG | |
| SCHEMBL21764400 | 0.75 | LPL (0.37) | KDM4ELPLLIPG | |
| SCHEMBL17072806 | 0.74 | LPL (0.36) | KDM4EALDH1A1LPLLIPGMAPT | |
| SCHEMBL19794970 | 0.74 | DRD1 (0.38) | LPLLIPG | |
| SCHEMBL19917100 | 0.72 | LPL (0.42) | JAK2BTKKDM4ELPLLIPG | |
| SCHEMBL24595409 | 0.72 | KDM4E (0.44) | KDM4EALDH1A1P2RX4GAARAB9A | |
| SCHEMBL22181581 | 0.71 | LPL (0.34) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10153443-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-12-11 | — | — | US | disclosed |
| US-20180026210-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-25 | — | — | US | disclosed |
| US-20180026210-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-25 | — | — | US | disclosed |
| US-20180026210-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10153443-B2 | Organic electroluminescent materials and devices | CACNA2D4, CACNA2D3, CACNA2D2 | JAK2 1995/4885BTK 1804/4885KDM4E 2363/4885 |
| US-20180026210-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CACNA2D4, CACNA2D3, CACNA2D2 | JAK2 1995/4885BTK 1804/4885KDM4E 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.